CRSP vs FSR
Crispr Therapeutics AG (CRSP) versus FSR (FSR) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
FSR (FSR) common stock.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
FSR does not have a complete income-statement cache yet.
CRSP currently screens at market cap $5.42B.
Not investment advice. Open the CRSP and FSR stock pages for the full models.
Not investment advice.